Cassava Sciences | PTIE - Capital Social Ordinario

Precio De Mercado
1.73
Cambio Diario
-0.03 -1.70%
Mensual
-9.42%
Anual
18.49%
Q2 Expectativa
1.60




Capital Social Ordinario Cambio Fecha
Abbott USD 1.74B 23.39B 2025-09
Amgen USD 539M 1000K 2025-12
Biogen USD 146.7M 200K 2025-09
Cara Therapeutics USD 9.38M 9.38M 2025-09
Cassava Sciences USD 48.31M 0 2025-12
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Geron USD 638.36M 338K 2025-12
J&J USD 2.41B 1.74M 2025-12
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.69B 1000K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12